1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Therapy Analysis & Statistics in Norway, July 2016

Therapy Analysis & Statistics in Norway, July 2016

1-13 of 13 reports

Purchase Reports From Reputable Market Research Publishers

2016-2020 Norway Clinical Chemistry and Immunodiagnostic Markets: Volume and Sales Forecasts for 100 Routine and Special Chemistries, Drugs of Abuse, Endocrine Function, Immunoproteins, Therapeutic Drug Monitoring (TDM), and Tumor Marker Tests--Emerging O

2016-2020 Norway Clinical Chemistry and Immunodiagnostic Markets: Volume and Sales Forecasts for 100 Routine and Special Chemistries, Drugs of Abuse, Endocrine Function, Immunoproteins, Therapeutic Drug Monitoring (TDM), and Tumor Marker Tests--Emerging O

  • $ 2 450
  • Industry report
  • May 2016
  • by Venture Planning Group

This new report from VPGMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and immunodiagnostic ...

  • Industries : Therapy
  • Countries : Norway
IMS Pharmaceutical Pricing & Reimbursement Concise Guide: Norway

IMS Pharmaceutical Pricing & Reimbursement Concise Guide: Norway

  • $ 1 610
  • Industry report
  • March 2016
  • by IMS Health

The Pharmaceutical Pricing & Reimbursement Concise Guides are established as the definitive reference and training text for P&R professionals around the world, drawing on the long-standing expertise of ...

  • Industries : Therapy, Pharmaceutical
  • Countries : Norway
KAEL Co., Ltd. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

KAEL Co., Ltd. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Therapy
  • Countries : Norway
Targovax AS - Product Pipeline Review - 2015

Targovax AS - Product Pipeline Review - 2015

  • $ 1 500
  • Company report
  • December 2015
  • by Global Markets Direct

Targovax AS - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘Targovax AS - Product Pipeline Review - 2015’, provides an overview of the Targovax AS’s pharmaceutical research and ...

  • Industries : Therapy, Research and Development, Biological Therapy
  • Countries : World, Norway, United States
Vaccibody AS - Product Pipeline Review - 2015

Vaccibody AS - Product Pipeline Review - 2015

  • $ 1 500
  • Company report
  • November 2015
  • by Global Markets Direct

Vaccibody AS - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘Vaccibody AS - Product Pipeline Review - 2015’, provides an overview of the Vaccibody AS’s pharmaceutical research ...

  • Industries : Biological Therapy, Biopharmaceutical, Therapy, Biotechnology, Research and Development
  • Countries : Norway
Weifa AS in Consumer Health (Norway)

Weifa AS in Consumer Health (Norway)

  • $ 143
  • Industry report
  • November 2015
  • by Euromonitor International

Weifa plans to solidify its position in the OTC category in Norway by maintaining its lead in analgesics and becoming a top three player in cough, cold and allergy (hay fever) remedies through the continued ...

  • Industries : Healthcare, Therapy, OTC
  • Countries : Norway
Insulin Market in Norway to 2019 - Market Size, Development, and Forecasts

Insulin Market in Norway to 2019 - Market Size, Development, and Forecasts

  • $ 652
  • Industry report
  • August 2015
  • by Global Research & Data Services

The industry report Insulin Market in Norway to 2019 - Market Size, Development, and Forecasts offers the most up-to-date market data on the actual market situation, and future outlook for insulin in Norway. ...

  • Industries : Therapy
  • Countries : Norway
Penicillin and Streptomycin Market in Norway to 2019 - Market Size, Development, and Forecasts

Penicillin and Streptomycin Market in Norway to 2019 - Market Size, Development, and Forecasts

  • $ 652
  • Industry report
  • August 2015
  • by Global Research & Data Services

The industry report Penicillin and Streptomycin Market in Norway to 2019 - Market Size, Development, and Forecasts offers the most up-to-date market data on the actual market situation, and future outlook ...

  • Industries : Therapy
  • Countries : Norway
PCI Biotech AS - Product Pipeline Review - 2015

PCI Biotech AS - Product Pipeline Review - 2015

  • $ 1 500
  • Company report
  • July 2015
  • by Global Markets Direct

PCI Biotech AS - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘PCI Biotech AS - Product Pipeline Review - 2015’, provides an overview of the PCI Biotech AS’s pharmaceutical research ...

  • Industries : Biotechnology, Cancer, Therapy
  • Countries : Norway
BerGenBio AS - Product Pipeline Review - 2015

BerGenBio AS - Product Pipeline Review - 2015

  • $ 1 500
  • Company report
  • May 2015
  • by Global Markets Direct

BerGenBio AS - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘BerGenBio AS - Product Pipeline Review - 2015’, provides an overview of the BerGenBio AS’s pharmaceutical research ...

  • Industries : Research and Development, Therapy, Cancer
  • Countries : Norway, World
Pharmaceuticals: Scandinavia Industry Guide

Pharmaceuticals: Scandinavia Industry Guide

  • $ 795
  • Industry report
  • May 2014
  • by MarketLine

Introduction The Scandinavian Pharmaceuticals industry guide provides top-line qualitative and quantitative summary information including: market size (value 2009-13, and forecast to 2018). The guide ...

  • Industries : Pharmaceutical, Therapy
  • Countries : Europe, Denmark, Norway, Sweden
Pharmaceuticals in Norway

Pharmaceuticals in Norway

  • $ 350
  • Industry report
  • April 2014
  • by MarketLine

Introduction Pharmaceuticals in Norway industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2009-13, and forecast to 2018). The ...

  • Industries : Pharmaceutical, Therapy
  • Countries : Norway
Physician Views: Bayer%s M&A catalyst – is Xofigo a paradigm shifter for the prostate cancer market?

Physician Views: Bayer%s M&A catalyst – is Xofigo a paradigm shifter for the prostate cancer market?

  • $ 754
  • Industry report
  • December 2013
  • by Firstword Pharma

Already positioned as one of the most commercially promising new drug approvals of 2013, Algeta and Bayer's prostate cancer treatment Xofigo is now driving what appears to be the inevitable acquisition ...

  • Industries : Therapy
  • Countries : Germany, Norway



ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.